BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21346054)

  • 1. Development of a multiplex bead-based assay for detection of hepatitis C virus.
    Fonseca BP; Marques CF; Nascimento LD; Mello MB; Silva LB; Rubim NM; Foti L; Silva ED; Ferreira AG; Krieger MA
    Clin Vaccine Immunol; 2011 May; 18(5):802-6. PubMed ID: 21346054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hepatitis C virus core antigen an adequate marker for community screening?
    Kuo YH; Chang KC; Wang JH; Tsai PS; Hung SF; Hung CH; Chen CH; Lu SN
    J Clin Microbiol; 2012 Jun; 50(6):1989-93. PubMed ID: 22461676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins.
    Araujo AC; Astrakhantseva IV; Fields HA; Kamili S
    J Clin Microbiol; 2011 Jan; 49(1):54-7. PubMed ID: 21084519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A protein array based on quantum dots (QDs) encoded microbeads for detection of hepatitis C virus].
    Liu J; Zhang GX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):67-9. PubMed ID: 23855136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.
    Jewett A; Smith BD; Garfein RS; Cuevas-Mota J; Teshale EH; Weinbaum CM
    J Clin Virol; 2012 Jul; 54(3):213-7. PubMed ID: 22560051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
    Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
    J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.
    Kesli R; Polat H; Terzi Y; Kurtoglu MG; Uyar Y
    J Clin Microbiol; 2011 Dec; 49(12):4089-93. PubMed ID: 21940466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
    Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
    Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein chip for detection of different HCV antibodies: preparation, quality control, and clinical evaluation.
    Zhang W; Huang J; Zhou MF; Chen LY; Ding YP; Cao HJ; Geng YY; Wang SQ
    Mol Diagn; 2005; 9(2):81-7. PubMed ID: 16137183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.
    Attallah AM; Ismail H; Tabll AA; Shiha GE; El-Dosoky I
    J Immunoassay Immunochem; 2003; 24(4):395-407. PubMed ID: 14677657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots.
    Brandão CP; Marques BL; Marques VA; Villela-Nogueira CA; Do Ó KM; de Paula MT; Lewis-Ximenez LL; Lampe E; Sá Ferreira JA; Villar LM
    J Clin Virol; 2013 Jun; 57(2):98-102. PubMed ID: 23518440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-antigen sandwich ELISA for the detection of anti-hepatitis C virus antibodies.
    He J; Xiu B; Wang G; Chen K; Feng X; Song X; Zhu C; Ling S; Zhang H
    J Virol Methods; 2011 Jan; 171(1):163-8. PubMed ID: 21029749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.
    González V; Martró E; Folch C; Esteve A; Matas L; Montoliu A; Grífols JR; Bolao F; Tural C; Muga R; Parry JV; Ausina V; Casabona J
    Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):121-6. PubMed ID: 18027006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.
    Chien DY; Arcangel P; Medina-Selby A; Coit D; Baumeister M; Nguyen S; George-Nascimento C; Gyenes A; Kuo G; Valenzuela P
    J Clin Microbiol; 1999 May; 37(5):1393-7. PubMed ID: 10203493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.